ロード中...
The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction
Although mesenchymal stem cells (MSC) have been shown to be safe in preclinical studies of cardiovascular disease, multiple meta-analyses have debated whether functional improvement is significant or not. The cardiac differentiation from MSC is achievable using cardiogenic factors, however, the high...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546480/ https://ncbi.nlm.nih.gov/pubmed/28498815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17471 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|